Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms.
OBJECTIVE
The natural history and management of pancreatic cysts, especially for branch duct intraductal papillary mucinous neoplasms (BD-IPMNs), remain uncertain. We developed evidence-based nomograms to assist with clinical decision making.


METHODS
We used decision analysis with Markov modeling to compare competing management strategies in a patient with a pancreatic head cyst radiographically suggestive of BD-IPMN, including the following: (1) initial pancreaticoduodenectomy (PD), (2) yearly noninvasive radiographic surveillance, (3) yearly invasive surveillance with endoscopic ultrasound, and (4) "do nothing." We derived probability estimates from a systematic literature review. The primary outcomes were overall and quality-adjusted survival. We depicted the results in a series of nomograms accounting for age, comorbidities, and cyst size.


RESULTS
Initial PD was the dominant strategy to maximize overall survival for any cyst greater than 2 cm, regardless of age or comorbidities. In contrast, surveillance was the dominant strategy for any lesion less than 1 cm. However, when measuring quality-adjusted survival, the do-nothing approach maximized quality of life for all cysts less than 3 cm in patients younger than age 75. Once age exceeded 85 years, noninvasive surveillance dominated. Initial PD did not maximize quality of life in any age group or cyst size.


CONCLUSIONS
Management of pancreatic cysts can be guided using novel Markov-based clinical nomograms, and depends on age, cyst size, comorbidities, and whether patients value overall survival vs quality-adjusted survival. For patients focused on overall survival, regardless of quality of life, surgery is optimal for lesions greater than 2 cm. For patients focused on quality-adjusted survival, a 3-cm threshold is more appropriate for surgery except for the extreme elderly.
Weinberg
Benjamin M
BM
Department of Gastroenterology, VA Greater Los Angeles Healthcare System, USA.
Spiegel
Brennan M R
BM
Tomlinson
James S
JS
Farrell
James J
JJ
D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D015331:Cohort Studies; D003661:Decision Support Techniques; D019160:Endosonography; D006801:Humans; D008390:Markov Chains; D049451:Nomograms; D010181:Pancreatic Cyst / Q000175:diagnosis* / Q000401:mortality*; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000401:mortality*; D016577:Pancreaticoduodenectomy; D011379:Prognosis; D011788:Quality of Life; D015996:Survival Rate